P03.09: Methodological approach to minimise costs: efficient implementation of hysterosonosalpingography in a tertiary hospital

Abstract

Objectives: Evaluate results, efficiency and safe of the HSSG as HyFoSy, as first diagnostic option for tubal patency from the point of view of the economic analysis based on the minimisation of costs against the HSG, which is presumed to have the same diagnostic efficiency. Methods: Descriptive retrospective observational study, between June 2017 and October 2018. All patients proposals for artificial insemination were included. We evaluated clinical, demographic and cost-efficiency variables. Results: Data were collected from a total of 257 patients. The pregnancy rate was 24.1%; no differences prior to 2016. The average delay to the appointment was 9 days, with an average number of 10 procedures a day. The diagnosis to the patient is inmediate. The cost of the test in our centre, adding direct and indirect costs is 90.85 euros; HSG costs 379.01 euros. The clinical and cost-efficiency variables are shown in figure 1. Conclusions:The HSSG is the first diagnostic option for tubal patency from the approach of minimisation of costs adding criteria of efficacy and safety. Is safe, fast and well tolerated by the patient. It is a very accessible self-managed technique, without waiting list, performed by a specialist with an immediate diagnostic result (effective) and of lower economic cost (efficient). Difficult to quantify but desirable in health that neither radiation nor use of contrasts are used, thus avoiding both possible teratogenic and allergic effects. Waiting time is an indicator of quality of a service. There are chained results of the time needed to perform, recovery time (nonexistent), and the index of potential activity (50/week).